FdaApplication
NDA 019174
Identifiers
- fda_app_no: NDA019174
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXOSMITHKLINE |
| application_type | NDA |
| approval_date | 1987-04-10 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TRANDATE HCT | HYDROCHLOROTHIAZIDE; LABETALOL HYDROCHLORIDE | 25MG;400MG | TABLET;ORAL |
| TRANDATE HCT | HYDROCHLOROTHIAZIDE; LABETALOL HYDROCHLORIDE | 25MG;200MG | TABLET;ORAL |
| TRANDATE HCT | HYDROCHLOROTHIAZIDE; LABETALOL HYDROCHLORIDE | 25MG;300MG | TABLET;ORAL |
| TRANDATE HCT | HYDROCHLOROTHIAZIDE; LABETALOL HYDROCHLORIDE | 25MG;100MG | TABLET;ORAL |
4 products